Stay updated on GLPG2737 in Combination With Orkambi Clinical Trial
Sign up to get notified when there's something new on the GLPG2737 in Combination With Orkambi Clinical Trial page.

Latest updates to the GLPG2737 in Combination With Orkambi Clinical Trial page
- CheckyesterdayChange DetectedThe page revision label was updated from v3.5.4 to v3.5.5, signaling a newer revision of the study record's metadata. This reflects a metadata update rather than a change to the substantive study content.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe sponsor field on the study record changed from Galapagos NV to Lakefront Biotherapeutics NV, reflecting a sponsor transition for the GLPG2737-CL-202 trial. This updates who is responsible for the study’s oversight and communications.SummaryDifference0.2%

- Check22 days agoChange DetectedThe page now shows revision: v3.5.4 replacing the previous v3.5.3, indicating a recent metadata/maintenance update rather than a substantive change to study content.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page’s footer/update label changed from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a website/version update rather than a change to the trial record.SummaryDifference0.1%

- Check51 days agoChange DetectedThe site revision was updated from v3.5.0 to v3.5.2. This appears to be a backend version update with no visible changes to the study details or content.SummaryDifference0.1%

- Check80 days agoChange DetectedThe site revision tag was updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

Stay in the know with updates to GLPG2737 in Combination With Orkambi Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG2737 in Combination With Orkambi Clinical Trial page.